CEBPA Gene Sequencing
Definition
Biallelic (double allele) mutations in the CEBPA gene are found in 2 to 15% of de novo AML patients and are defined as a separate disease entity in the WHO classification. Unlike single-allele mutations, biallelic mutations (especially those in the bZIP region) are significantly associated with better event-free and overall survival.
Gene/Region Examined
CEBPA Exon 1
Method
DNA analysis
Accepted Sample Types
Fresh tumor tissue, FFPE
Inheritance
Mostly somatic, but in rare familial AML syndromes a germline mutation may be found in one allele of CEBPA; in these cases a somatic mutation is later added to the second allele, making it biallelic.